Rising Prevalence Of Infectious Diseases To Drive Market Growth: An Emerging Driver Transforming The Viral Inactivation Market Landscape

The Viral Inactivation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Viral Inactivation Market?
The Viral Inactivation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Viral Inactivation Market?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

What Are the Different Viral Inactivation Market Segments?
The viral inactivation market covered in this report is segmented -

1) By Product: Kits And Reagents, Systems, Services
2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:
1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes
2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems
3) By Services: Viral Testing Services, Validation Services, Consulting Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

What Are the Primary Drivers Shaping the Viral Inactivation Market?
The increase in various infectious diseases is likely to drive the expansion of the viral inactivation market. Infectious diseases, which can be spread through contaminated food and drink, and via pathogens such as bacteria, viruses, fungi, and parasites, play a major role in this trend. Viral inactivation, a method that employs physical and chemical disinfectants to neutralize viruses, is primarily used in human disease-control programs to curb the proliferation of infectious viral conditions, subsequently boosting the viral inactivation market. For example, statistics from the Centers for Disease Control and Prevention, a US national public health agency, indicated an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, a rise of 1,295 cases. The rate also rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Consequently, the surge in various infectious diseases is contributing to the growth of the viral inactivation market.

Which Companies Are Leading in the Viral Inactivation Market?
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

What Are the Major Trends Shaping the Viral Inactivation Market?
A key trend emerging in the viral inactivation market is the increasing adoption of technology-driven processes. In a bid to maintain their market stance, companies in this market sphere are utilizing advanced technological measures. A case in point is the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology in March 2022 by WuXi Advanced Therapies, a fully owned subsidiary of WuXi AppTec, a biopharmaceutical enterprise based in China. This groundbreaking technology has paved the way for the sanctioning of new treatments by concurrently conducting all assay formulation, biosafety, viral clearance, product release, and testing, all within the premises. This innovation offers an entirely new approach to producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade, eliminating the necessity for transfection.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

What Are the Top Revenue-Generating Geographies in the Viral Inactivation Market?
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Viral Inactivation Market?
2. What is the CAGR expected in the Viral Inactivation Market?
3. What Are the Key Innovations Transforming the Viral Inactivation Industry?
4. Which Region Is Leading the Viral Inactivation Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.